Tag: pfizer

pfizer

Latest News

Korean court rules for the first time that Pfizer vaccine caused death

The court’s first ruling recognizing a Pfizer vaccine death from TTS may widen the path to government compensation for similar cases.

2026.6.10

Researchers at SK bioscience analyze their findings in a photo shared by the company on Feb. 12. [YONHAP]

SK bioscience wins patent dispute against Pfizer over pneumococcal vaccine

SK bioscience, a biotech arm of Korea's SK Group, said Wednesday it has won a patent lawsuit against global pharmaceutical giant Pfizer over pneumococcal vaccine components.

2025.5.21

Most popular

European Commission President Ursula von der Leyen attends a European Commission College meeting in Brussels, Belgium, on May 14. [EPA/YONHAP]

Court rules in favor of the New York Times over texts between an EU chief and a pharma boss

A top European court ruled on Wednesday that the European Commission was wrong to refuse the New York Times access to text messages sent between President Ursula von der Leyen and a pharmaceutical boss during the Covid-19 pandemic.

2025.5.14

Pfizer ends development of weight-loss pill danuglipron

Pfizer on Monday said it had discontinued the development of the experimental weight-loss pill danuglipron after a trial patient experienced a potential drug-induced liver injury, which resolved after the medication was stopped.

2025.4.14

Pfizer Korea Country Manager Oh Dong-wook gives an opening speech at a press event regarding the regulatory approval of Pfizer's latest pneumococcal vaccine at Lotte Hotel in central Seoul on Tuesday. [PFIZER KOREA]

Pfizer's enhanced pneumococcal vaccine arriving in Korea next year

Pfizer plans to launch Prevnar 20, a new pneumococcal vaccine, in Korea early next year, offering broader protection than Prevnar 13.

2024.11.19

A digital render of Samsung Biologics' Plant 5 in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics orders hit 3 trillion won in historic milestone

Samsung Biologics has secured five biomanufacturing contracts, bringing the total of its 2023 orders to over 3 trillion won for the first time since its foundation.

2023.11.28

Samsung Biologics CEO John Rim speaks during a press event at its headquarters in Incheon. [SAMSUNG BIOLOGICS]

Samsung Biologics has blowout Q3, revenues hit new high

Samsung Biologics posted a consensus-beating 320 billion won ($240 million) in operating profit in the third quarter, with revenues surpassing 1 trillion won for the first time in its history.

2023.10.25

A rendered image of Samsung Biologics' Plant 5 in Songdo, Incheon. [SAMSUNG BIOLOGICS]

Samsung Biologics lands further Pfizer deals in record year

Pharmaceutical manufacturer Samsung Biologics has secured $897 million worth of deals from Pfizer Ireland Pharmaceuticals, the Incheon-based company said Tuesday.

2023.7.4

John Rim, Samsung Biologics CEO, speaks during a press conference held in Boston on Monday. [YONHAP]

Samsung Biologics signs record CMO deal with Pfizer

Samsung Biologics inked a $411 million contract manufacturing organization (CMO) letter of intent with Pfizer Ireland Pharmaceuticals, the biggest single deal the Korean company ever signed.

2023.6.8

Jung Ki-suck, professor of pulmonary medicine at Hallym University Sacred Heart Hospital, speaks at a press briefing for Pfizer Korea's 2022 Vaccine Class on Tuesday at the Lotte Hotel Seoul in central Seoul. [PFIZER KOREA]

Anti-pneumonia vaccine recommended by expert

A top health expert called for people to get pneumococcal vaccines to guard against long Covid deteriorating into pneumonia.

2022.6.14